The Flu Vaccine Breakthrough and What It Means for the Future of mRNA Technology The recent approval of mFLUSIVA, the first mRNA influenza vaccine in the United States, has been met with a lukewarm response from the public health community.
Despite being a major breakthrough in vaccination technology, the news has barely registered outside of medical circles.
However, what's remarkable about this story isn't just the achievement itself but also the context that surrounds it.